45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transition state analogues of 5′-methylthioadenosine nucleosidase disrupt quorum sensing

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          5′-Methylthioadenosine nucleosidase (MTAN) is a bacterial enzyme involved in S-adenosylmethionine-related quorum sensing pathways that induce bacterial pathogenesis factors. Transition state analogues 5′-methylthio- (MT-), 5′-ethylthio- (EtT-) and 5′-butylthio- (BuT-) DADMe-ImmucillinAs are slow-onset, tight-binding inhibitors of Vibrio cholerae MTAN ( VcMTAN), with dissociation constants of 73, 70, and 208 pM, respectively. Structural analysis of VcMTAN with BuT-DADMe-ImmucillinA reveals interactions contributing to the high affinity. In V. cholerae cells, these compounds are potent MTAN inhibitors with IC 50 values of 27, 31, and 6 nM for MT-, EtT-, and BuT-DADMe-ImmucillinA, disrupting autoinducer production in a dose-dependent manner without affecting growth. MT- and BuT-DADMe-ImmucillinA also inhibit autoinducer-2 production in enterohemorrhagic Escherichia coli O157:H7 with IC 50 values of 600, and 125 nM, respectively. BuT-DADMe-ImmucillinA inhibition of autoinducer-2 production in both strains persists for several generations, and causes reduction in biofilm formation. These results support MTAN’s role in quorum sensing, and its potential as target for bacterial anti-infective drug design.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: not found
          • Article: not found

          Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A graphical user interface to the CCP4 program suite.

            CCP4i is a graphical user interface that makes running programs from the CCP4 suite simpler and quicker. It is particularly directed at inexperienced users and tightly linked to introductory and scientific documentation. It also provides a simple project-management system and visualization tools. The system is readily extensible and not specific to CCP4 software.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The biology and future prospects of antivirulence therapies.

              The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches. Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium. Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others. Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.
                Bookmark

                Author and article information

                Journal
                101231976
                32624
                Nat Chem Biol
                Nature chemical biology
                1552-4450
                1552-4469
                9 February 2009
                8 March 2009
                April 2009
                1 October 2009
                : 5
                : 4
                : 251-257
                Affiliations
                Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 10461
                Author notes
                [* ]Corresponding author: Vern L. Schramm, Telephone (718) 430-2813, Fax (718) 430-8565, Email vern@ 123456aecom.yu.edu
                Article
                nihpa93166
                10.1038/nchembio.153
                2743263
                19270684
                d976952c-04dd-4cbd-85bf-06ce28088a84
                History
                Funding
                Funded by: National Institute of General Medical Sciences : NIGMS
                Award ID: R37 GM041916-19 ||GM
                Categories
                Article

                Biochemistry
                Biochemistry

                Comments

                Comment on this article